FOURTH SUPPLEMENTAL INDENTUREFourth Supplemental Indenture • January 2nd, 2018 • Allergan PLC • Pharmaceutical preparations • New York
This Fourth Supplemental Indenture, dated as of January 1, 2018 (this “Supplemental Indenture”), among Allergan Sales, LLC, a Delaware limited liability company (the “Company”), as successor in interest to Forest Laboratories, LLC, a Delaware limited liability company (“Forest Labs”), Allergan plc, an Irish public limited company, as guarantor (the “Parent Guarantor”), and Wells Fargo Bank, National Association, a national banking association, as Trustee (the “Trustee”) under the Indenture referred to below.
